WELIMERO 1 GM contains Meropenem 1 g Injection, a broad-spectrum carbapenem positioned for serious susceptible bacterial infections requiring hospital-based parenteral therapy. Its extensive antibacterial coverage and stability against many beta-lactamases make it particularly relevant to specialist, critical-care and institutional practice. The product provides a premium option within a PCD Pharma Injectable Antibiotic portfolio, with strong positioning for physician and hospital-oriented anti-infective requirements.
Serious susceptible bacterial infections, particularly when broad-spectrum hospital therapy is clinically justified.
It is commonly reserved for serious or resistant infections where carbapenem therapy is appropriate.
No.
Use only under specialist or hospital supervision and according to appropriate antimicrobial policies. Renal function is especially important because dosage adjustment may be required. Consider culture and susceptibility information whenever possible. Monitor neurological status, allergy reactions and clinical response. Avoid unnecessary carbapenem use to preserve effectiveness against antimicrobial resistance.
Diarrhea, nausea, vomiting, headache, rash, injection-site reactions and infusion-related discomfort may occur. Altered liver enzymes or blood counts may occasionally develop. Neurological adverse effects, including seizures, are uncommon but clinically important, particularly in patients with renal impairment or underlying neurological susceptibility. Serious hypersensitivity reactions are possible. Persistent diarrhea, severe rash, confusion, unusual movements or seizures require urgent medical evaluation.
WELIMERO 1 GM: Meropenem is a carbapenem antibiotic that penetrates bacterial cells and binds to multiple penicillin-binding proteins, strongly inhibiting cell-wall synthesis. This broad mechanism produces bactericidal activity against many susceptible Gram-positive and Gram-negative organisms. Its stability against many beta-lactamases contributes to its broad spectrum. Because of its reserve role and broad activity, it is generally used for serious infections where resistant pathogens or complex hospital-acquired infections are a concern.
